Financings in Brief: Medtronic/Neurex Corporation
This article was originally published in The Gray Sheet
Executive Summary
Medtronic/Neurex Corporation: Neurex secures an $8 mil. convertible loan from Medtronic under the terms of an April 1994 agreement between the two firms. The $8 mil. will convert to common stock after Neurex "has raised a mutually agreed amount of equity financing," the firms say. Medtronic and Neurex entered an agreement in April 1994 to commercialize Neurex' SNX-111 neuron-specific calcium channel blocker for chronic neuropathic pain via direct administration with Medtronic's SynchroMed implantable programmable drug pump ("The Gray Sheet" May 2, 1994, In Brief). The loan is "aimed at significantly strengthening Neurex' financial position," the companies say...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.